Clinical trial
A Proof-of-Concept, Multicenter, Randomized, Double-Blind, Parallel Study of Naltrexone Sustained-Release (SR) and/or Fluoxetine Therapy in the Treatment of Subjects With Obsessive-Compulsive Disorder (OCD)
NCT00758966 is registered in ClinicalTrials.gov with Orexigen Therapeutics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Proof-of-Concept, Multicenter, Randomized, Double-Blind, Parallel Study of Naltrexone Sustained-Release (SR) and/or Fluoxetine Therapy in the Treatment of Subjects With Obsessive-Compulsive Disorder (OCD)
- Lead sponsor
- Orexigen Therapeutics, Inc
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2008
- Completion date
- December 31, 2008
- Enrollment
- 8 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.